Amarin Corp Plc (AMRN)

[ziploc_1]

Capt...While the author of the SA article puts a buy recommendation on Amarin, he hedges his bet by discussing just about all of the present negatives and leaving out some of the more important potential positives...including MD2119 once a day formulations and combo formulations with a statin, the Mitigate and Respect studies, and China approval of Vascepa expected this year.

In addition, he puts an artificially low target price of 2 to 3 billion dollars on Amarin.......he also repeats the phrase mentioned in the Q2 report .."we have enough cash for the next 12 months"...which is a standard statement, appearing in every quarterly report....in order to further worry potential investors about the extremely unlikely scenario of bankruptcy. He seems to be advocating for a BO of Amarin on the cheap.